Geode Capital Management »

Bioxcel Therapeutics shares owned by Geode Capital Management

Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Geode Capital Management from 13F filings

Historical chart of Geode Capital Management investment in Bioxcel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bioxcel Therapeutics held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioxcel Therapeutics by Geode Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.3M 458k 2.82
2023-09-30 $1.1M 423k 2.53
2023-06-30 $2.7M 405k 6.66
2023-03-31 $7.1M 383k 18.66
2022-12-31 $8.1M 375k 21.48
2022-09-30 $4.2M 356k 11.82
2022-06-30 $4.5M 344k 13.20
2022-03-31 $6.5M 312k 20.91
2021-12-31 $6.1M 301k 20.33
2021-09-30 $9.0M 297k 30.35
2021-06-30 $8.0M 277k 29.06
2021-03-31 $11M 253k 43.16
2020-12-31 $10M 224k 46.20
2020-09-30 $8.9M 206k 43.36
2020-06-30 $8.6M 161k 53.00
2020-03-31 $3.0M 136k 22.35
2019-12-31 $1.2M 79k 14.61
2019-09-30 $435k 62k 7.03
2019-06-30 $662k 60k 10.95
2019-03-31 $250k 25k 9.87